Concepedia
Statistics
Publications
6
Citations
187
H-Index
Active since
2016
Affiliations
Iowa State University(Current)
NovaBiotics (United Kingdom)
Reformed Theological College
Thomas De Ridder is an author at Iowa State University specializing in medicine, pharmacotherapy, and pharmacology.
Top concepts
MedicineBiologyGeneticsOncologyVirologyPathologyImmunologyPathogenesisPharmacologyImmunotherapy
Publications per year
2016–2022
Randomized controlled clinical study evaluating the efficacy and safety of intratumoral treatment of canine mast cell tumors with tigilanol tiglate (EBC-46)
Thomas De Ridder, Justine E. Campbell, Cheryl Burke‐Schwarz et al. · Journal of Veterinary Internal Medicine · 2020 · 65 citations · Full text
Topical, immunomodulatory epoxy-tiglianes induce biofilm disruption and healing in acute and chronic skin wounds
Lydia C. Powell, Jason K. Cullen, Glen M. Boyle et al. · Science Translational Medicine · 2022 · 40 citations
Intratumoural Treatment of 18 Cytologically Diagnosed Canine High-Grade Mast Cell Tumours With Tigilanol Tiglate
Graham Brown, Justine E. Campbell, P. Jones et al. · Frontiers in Veterinary Science · 2021 · 24 citations · Full text
Genomic characterization of a novel poxvirus from a flying fox: evidence for a new genus?
Mark O’Dea, Shin-Lin Tu, Stanley Pang et al. · Journal of General Virology · 2016 · 20 citations
Genetics, Pathology, Novel Poxvirus +17
Wound formation, wound size, and progression of wound healing after intratumoral treatment of mast cell tumors in dogs with tigilanol tiglate
Paul Reddell, Thomas De Ridder, John M. Morton et al. · Journal of Veterinary Internal Medicine · 2021 · 20 citations · Full text
1–5 of 6